CTLA4 and melanoma: Although CTLA-4 ICB-mediated depletion of tumour-infiltrating regulatory T cells has not been observed in human cancers such as melanoma, prostate and bladder cancers, an increase in tumour-infiltrating CD4+ and CD8+ cells has been reported [30].